The Omega-3 Index (percentage of EPA and DHA in red blood cells) is discussed as a biomarker for cardiovascular health and potentially longevity. Observational studies show an inverse association between a high index (>8%) and risk of sudden cardiac death and all-cause mortality. However, the evidence is largely associative; randomized controlled trials with longevity as an endpoint are lacking. The index is influenced by diet (fish, algae oil), supplementation, and genetic factors (e.g., FADS1/2 variants). An isolated high index does not guarantee extended lifespan – it is a marker, not a determinant. Caution against overinterpretation: an optimal index can be part of a healthy lifestyle but does not replace other preventive measures. Combining it with other biomarkers (e.g., hs-CRP, vitamin D) and DNA analyses (e.g., APOE, FOXO3) may provide a more comprehensive picture, but remains experimental. Bottom line: monitor the Omega-3 Index, but do not view it as a standalone longevity indicator. Evidence: human-moderate.
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-f6aaf20ca4cb035dd4a1bcf3